A Game-Changing Drug for Pancreatic Cancer Just Got FDA Approval by Ed Cara from Gizmodo on 2026-08-26 19:05 (#77Z51) In a large-scale clinical trial, people taking daraxonrasib lived twice as long as those given standard chemotherapy.
